The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gene-based Advanced Therapy Medical Product Market Research Report 2025
Synopsis
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global Gene-based Advanced Therapy Medical Product market was valued at US$ 9063 million in 2023 and is anticipated to reach US$ 34850 million by 2030, witnessing a CAGR of 20.2% during the forecast period 2024-2030.
The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.
This report aims to provide a comprehensive presentation of the global market for Gene-based Advanced Therapy Medical Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene-based Advanced Therapy Medical Product.
Report Scope
The Gene-based Advanced Therapy Medical Product market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene-based Advanced Therapy Medical Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene-based Advanced Therapy Medical Product companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Segment by Type
Viral Gene Delivery System
Non-viral Gene Delivery System
Segment by Application
Neurological Diseases
Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene-based Advanced Therapy Medical Product companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global Gene-based Advanced Therapy Medical Product market was valued at US$ 9063 million in 2023 and is anticipated to reach US$ 34850 million by 2030, witnessing a CAGR of 20.2% during the forecast period 2024-2030.
The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.
This report aims to provide a comprehensive presentation of the global market for Gene-based Advanced Therapy Medical Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene-based Advanced Therapy Medical Product.
Report Scope
The Gene-based Advanced Therapy Medical Product market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene-based Advanced Therapy Medical Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene-based Advanced Therapy Medical Product companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Segment by Type
Viral Gene Delivery System
Non-viral Gene Delivery System
Segment by Application
Neurological Diseases
Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene-based Advanced Therapy Medical Product companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene-based Advanced Therapy Medical Product Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Gene-based Advanced Therapy Medical Product Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene-based Advanced Therapy Medical Product Market Perspective (2019-2030)
2.2 Gene-based Advanced Therapy Medical Product Growth Trends by Region
2.2.1 Global Gene-based Advanced Therapy Medical Product Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene-based Advanced Therapy Medical Product Historic Market Size by Region (2019-2024)
2.2.3 Gene-based Advanced Therapy Medical Product Forecasted Market Size by Region (2025-2030)
2.3 Gene-based Advanced Therapy Medical Product Market Dynamics
2.3.1 Gene-based Advanced Therapy Medical Product Industry Trends
2.3.2 Gene-based Advanced Therapy Medical Product Market Drivers
2.3.3 Gene-based Advanced Therapy Medical Product Market Challenges
2.3.4 Gene-based Advanced Therapy Medical Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene-based Advanced Therapy Medical Product Players by Revenue
3.1.1 Global Top Gene-based Advanced Therapy Medical Product Players by Revenue (2019-2024)
3.1.2 Global Gene-based Advanced Therapy Medical Product Revenue Market Share by Players (2019-2024)
3.2 Global Gene-based Advanced Therapy Medical Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene-based Advanced Therapy Medical Product Revenue
3.4 Global Gene-based Advanced Therapy Medical Product Market Concentration Ratio
3.4.1 Global Gene-based Advanced Therapy Medical Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene-based Advanced Therapy Medical Product Revenue in 2023
3.5 Gene-based Advanced Therapy Medical Product Key Players Head office and Area Served
3.6 Key Players Gene-based Advanced Therapy Medical Product Product Solution and Service
3.7 Date of Enter into Gene-based Advanced Therapy Medical Product Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene-based Advanced Therapy Medical Product Breakdown Data by Type
4.1 Global Gene-based Advanced Therapy Medical Product Historic Market Size by Type (2019-2024)
4.2 Global Gene-based Advanced Therapy Medical Product Forecasted Market Size by Type (2025-2030)
5 Gene-based Advanced Therapy Medical Product Breakdown Data by Application
5.1 Global Gene-based Advanced Therapy Medical Product Historic Market Size by Application (2019-2024)
5.2 Global Gene-based Advanced Therapy Medical Product Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene-based Advanced Therapy Medical Product Market Size (2019-2030)
6.2 North America Gene-based Advanced Therapy Medical Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene-based Advanced Therapy Medical Product Market Size by Country (2019-2024)
6.4 North America Gene-based Advanced Therapy Medical Product Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene-based Advanced Therapy Medical Product Market Size (2019-2030)
7.2 Europe Gene-based Advanced Therapy Medical Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene-based Advanced Therapy Medical Product Market Size by Country (2019-2024)
7.4 Europe Gene-based Advanced Therapy Medical Product Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size (2019-2030)
8.2 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene-based Advanced Therapy Medical Product Market Size (2019-2030)
9.2 Latin America Gene-based Advanced Therapy Medical Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene-based Advanced Therapy Medical Product Market Size by Country (2019-2024)
9.4 Latin America Gene-based Advanced Therapy Medical Product Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size (2019-2030)
10.2 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene-based Advanced Therapy Medical Product Introduction
11.1.4 Biogen Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene-based Advanced Therapy Medical Product Introduction
11.2.4 Novartis Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Detail
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene-based Advanced Therapy Medical Product Introduction
11.3.4 Gilead Sciences Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Detail
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Detail
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene-based Advanced Therapy Medical Product Introduction
11.6.4 Amgen Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Detail
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene-based Advanced Therapy Medical Product Introduction
11.7.4 Spark Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Detail
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medical Product Introduction
11.8.4 Akcea Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024)
11.8.5 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Detail
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene-based Advanced Therapy Medical Product Introduction
11.9.4 bluebird bio Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024)
11.9.5 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Detail
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene-based Advanced Therapy Medical Product Introduction
11.10.4 Sunway Biotech Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Detail
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene-based Advanced Therapy Medical Product Introduction
11.11.4 SIBIONO Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Detail
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene-based Advanced Therapy Medical Product Introduction
11.12.4 AnGes Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Detail
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene-based Advanced Therapy Medical Product Introduction
11.13.4 Orchard Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Detail
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Introduction
11.14.4 Human Stem Cells Institute Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024)
11.14.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Gene-based Advanced Therapy Medical Product Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Viral Gene Delivery System
Table 3. Key Players of Non-viral Gene Delivery System
Table 4. Global Gene-based Advanced Therapy Medical Product Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Gene-based Advanced Therapy Medical Product Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Gene-based Advanced Therapy Medical Product Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Gene-based Advanced Therapy Medical Product Market Share by Region (2019-2024)
Table 8. Global Gene-based Advanced Therapy Medical Product Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Gene-based Advanced Therapy Medical Product Market Share by Region (2025-2030)
Table 10. Gene-based Advanced Therapy Medical Product Market Trends
Table 11. Gene-based Advanced Therapy Medical Product Market Drivers
Table 12. Gene-based Advanced Therapy Medical Product Market Challenges
Table 13. Gene-based Advanced Therapy Medical Product Market Restraints
Table 14. Global Gene-based Advanced Therapy Medical Product Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Gene-based Advanced Therapy Medical Product Market Share by Players (2019-2024)
Table 16. Global Top Gene-based Advanced Therapy Medical Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene-based Advanced Therapy Medical Product as of 2023)
Table 17. Ranking of Global Top Gene-based Advanced Therapy Medical Product Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Gene-based Advanced Therapy Medical Product Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene-based Advanced Therapy Medical Product Product Solution and Service
Table 21. Date of Enter into Gene-based Advanced Therapy Medical Product Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene-based Advanced Therapy Medical Product Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Gene-based Advanced Therapy Medical Product Revenue Market Share by Type (2019-2024)
Table 25. Global Gene-based Advanced Therapy Medical Product Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Gene-based Advanced Therapy Medical Product Revenue Market Share by Type (2025-2030)
Table 27. Global Gene-based Advanced Therapy Medical Product Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Gene-based Advanced Therapy Medical Product Revenue Market Share by Application (2019-2024)
Table 29. Global Gene-based Advanced Therapy Medical Product Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Gene-based Advanced Therapy Medical Product Revenue Market Share by Application (2025-2030)
Table 31. North America Gene-based Advanced Therapy Medical Product Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Gene-based Advanced Therapy Medical Product Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Gene-based Advanced Therapy Medical Product Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Gene-based Advanced Therapy Medical Product Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Gene-based Advanced Therapy Medical Product Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Gene-based Advanced Therapy Medical Product Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gene-based Advanced Therapy Medical Product Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Gene-based Advanced Therapy Medical Product Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Gene-based Advanced Therapy Medical Product Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Country (2025-2030) & (US$ Million)
Table 46. Biogen Company Detail
Table 47. Biogen Business Overview
Table 48. Biogen Gene-based Advanced Therapy Medical Product Product
Table 49. Biogen Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Gene-based Advanced Therapy Medical Product Product
Table 54. Novartis Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Detail
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Gene-based Advanced Therapy Medical Product Product
Table 59. Gilead Sciences Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Sarepta Therapeutics Company Detail
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Product
Table 64. Sarepta Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024) & (US$ Million)
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Pharmaceuticals Company Detail
Table 67. Alnylam Pharmaceuticals Business Overview
Table 68. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Product
Table 69. Alnylam Pharmaceuticals Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024) & (US$ Million)
Table 70. Alnylam Pharmaceuticals Recent Development
Table 71. Amgen Company Detail
Table 72. Amgen Business Overview
Table 73. Amgen Gene-based Advanced Therapy Medical Product Product
Table 74. Amgen Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Spark Therapeutics Company Detail
Table 77. Spark Therapeutics Business Overview
Table 78. Spark Therapeutics Gene-based Advanced Therapy Medical Product Product
Table 79. Spark Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024) & (US$ Million)
Table 80. Spark Therapeutics Recent Development
Table 81. Akcea Therapeutics Company Detail
Table 82. Akcea Therapeutics Business Overview
Table 83. Akcea Therapeutics Gene-based Advanced Therapy Medical Product Product
Table 84. Akcea Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024) & (US$ Million)
Table 85. Akcea Therapeutics Recent Development
Table 86. bluebird bio Company Detail
Table 87. bluebird bio Business Overview
Table 88. bluebird bio Gene-based Advanced Therapy Medical Product Product
Table 89. bluebird bio Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024) & (US$ Million)
Table 90. bluebird bio Recent Development
Table 91. Sunway Biotech Company Detail
Table 92. Sunway Biotech Business Overview
Table 93. Sunway Biotech Gene-based Advanced Therapy Medical Product Product
Table 94. Sunway Biotech Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024) & (US$ Million)
Table 95. Sunway Biotech Recent Development
Table 96. SIBIONO Company Detail
Table 97. SIBIONO Business Overview
Table 98. SIBIONO Gene-based Advanced Therapy Medical Product Product
Table 99. SIBIONO Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024) & (US$ Million)
Table 100. SIBIONO Recent Development
Table 101. AnGes Company Detail
Table 102. AnGes Business Overview
Table 103. AnGes Gene-based Advanced Therapy Medical Product Product
Table 104. AnGes Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024) & (US$ Million)
Table 105. AnGes Recent Development
Table 106. Orchard Therapeutics Company Detail
Table 107. Orchard Therapeutics Business Overview
Table 108. Orchard Therapeutics Gene-based Advanced Therapy Medical Product Product
Table 109. Orchard Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024) & (US$ Million)
Table 110. Orchard Therapeutics Recent Development
Table 111. Human Stem Cells Institute Company Detail
Table 112. Human Stem Cells Institute Business Overview
Table 113. Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Product
Table 114. Human Stem Cells Institute Revenue in Gene-based Advanced Therapy Medical Product Business (2019-2024) & (US$ Million)
Table 115. Human Stem Cells Institute Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene-based Advanced Therapy Medical Product Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Gene-based Advanced Therapy Medical Product Market Share by Type: 2023 VS 2030
Figure 3. Viral Gene Delivery System Features
Figure 4. Non-viral Gene Delivery System Features
Figure 5. Global Gene-based Advanced Therapy Medical Product Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Gene-based Advanced Therapy Medical Product Market Share by Application: 2023 VS 2030
Figure 7. Neurological Diseases Case Studies
Figure 8. Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. Gene-based Advanced Therapy Medical Product Report Years Considered
Figure 11. Global Gene-based Advanced Therapy Medical Product Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Gene-based Advanced Therapy Medical Product Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Gene-based Advanced Therapy Medical Product Market Share by Region: 2023 VS 2030
Figure 14. Global Gene-based Advanced Therapy Medical Product Market Share by Players in 2023
Figure 15. Global Top Gene-based Advanced Therapy Medical Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene-based Advanced Therapy Medical Product as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Gene-based Advanced Therapy Medical Product Revenue in 2023
Figure 17. North America Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Gene-based Advanced Therapy Medical Product Market Share by Country (2019-2030)
Figure 19. United States Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Gene-based Advanced Therapy Medical Product Market Share by Country (2019-2030)
Figure 23. Germany Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Share by Region (2019-2030)
Figure 31. China Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Gene-based Advanced Therapy Medical Product Market Share by Country (2019-2030)
Figure 39. Mexico Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Share by Country (2019-2030)
Figure 43. Turkey Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Biogen Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2019-2024)
Figure 46. Novartis Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2019-2024)
Figure 47. Gilead Sciences Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2019-2024)
Figure 48. Sarepta Therapeutics Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2019-2024)
Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2019-2024)
Figure 50. Amgen Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2019-2024)
Figure 51. Spark Therapeutics Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2019-2024)
Figure 52. Akcea Therapeutics Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2019-2024)
Figure 53. bluebird bio Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2019-2024)
Figure 54. Sunway Biotech Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2019-2024)
Figure 55. SIBIONO Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2019-2024)
Figure 56. AnGes Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2019-2024)
Figure 57. Orchard Therapeutics Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2019-2024)
Figure 58. Human Stem Cells Institute Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
